en · de · es · fr · pt
thymosin-alpha-1-notes.peptides9002.com › Data › �ˆ†子身份与天然来源 — Questions and Answers

�ˆ†子身份与天然来源 — Questions and Answers

By Editorial Desk · published 2026-03-20 · last reviewed 2026-04-28 · Data

The short version of thymus extract fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2026-04-28 and is reviewed periodically as new material appears.

分子身份与天然来源

20世纪70年代,研究者从胸腺提取物中纯化出多种小肽,Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤,产量低且成分复杂。随着固相肽合成技术成熟,实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上,并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。

市售的胸腺素α1通常以冻干粉形式提供,溶解后用于注射。其氨基酸组成包括多个酸性残基,因此在中性pH下带负电荷。该肽可溶于水和生理盐水,但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度,溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。

胸腺素α1(thymosin alpha 1,Tα1)是一种由28个氨基酸组成的酸性肽,N端被乙酰化,分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离,属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守,提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置,并非表示亚型编号。它既存在于胸腺,也存在于脾脏和淋巴结等免疫组织。

Molecular Structure and Biological Background

The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.

Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.

Thymosin-alpha-1 at a glance

PropertyValueNotes
化学分类线性肽由28个氨基酸组成
分子量约3108 Da合成版本一致
外观白色至类白色粉末冻干品
溶解度易溶于水微溶于有机溶剂
储存温度-20°C(冻干)溶解后2-8°C

Handling, Storage, and Analytical Verification

Stability depends on temperature, pH, and the number of freeze-thaw events the sample has experienced. Freeze-dried material is commonly held at -20 °C or colder, while reconstituted liquid is kept cold and used within a short window. Extreme pH and prolonged light exposure can promote deamidation, oxidation, or aggregation, particularly at asparagine and methionine positions. Adsorption to container walls can lower the measured concentration of a dilute solution even when the peptide molecules themselves remain intact.

Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.

Related pages on this site

Molecular Background and Identity

Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.

Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.

Molecular Identity Of Thymosin Alpha-1

Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.

Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.

Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.

Research History and Clinical Assessment

Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.

Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.

Background from the literature

=== In pharmacology === Bioavailability is a term used to describe the percentage of an administered dose of a xenobiotic that reaches the systemic circulation unchanged. It is denoted by the letter f (or, if expressed in percent, by F).

In this model an infection does not leave any immunity thus individuals that have recovered return to being susceptible, moving back into the S(t) compartment. The following differential equations describe this model:

=== May === 1 May: 5,000 senior doctors affiliated with the Association of Salaried Medical Specialists strike in response to a pay dispute with national health service Health New Zealand. States of emergency are declared in Selwyn District, Christchurch and Banks Peninsula due to flooding and landslides, amid poor weather affecting most of the country. About a thousand properties in Wellington experience power outages. Most flights to and from the city are cancelled, and so are Cook Strait ferry crossings. Wind gusts in the city reach up to 150 km/h. 2 May – The state of emergency is lifted in the Selwyn District. States of emergency remain in effect in Christchurch and Banks Peninsula. 3 May – 400 protesters gather in Dunedin's Octagon to protest against the New Zealand First party's member's bill defining women and men based on their sexual biology. 6 May – The Commerce Commission files criminal charges against supermarket giant Woolworths for alleged inaccurate pricing and misleading discounts. 7 May: Convicted murderer Mark Lundy is released on parole after serving 23 years of a life sentence for the murders of his wife Christine and daughter Amber in August 2000. The New Zealand Government ends the requirement for overseas visitors to provide certified translations of supporting documents in a bid to boost tourism. The New Zealand Parliament passes urgent legislation raising the threshold for making pay equity claims. As a result, 33 claims representing thousands of workers have to be dropped and refiled.

== Classification of MMC == MMC can be classified into physical MMC and chemical MMC. In the former method, the stationary phase is constructed of two or more types of packing materials. In the chemical method, just one type of packing material containing two or more functionalities is used.

== Factor XIII deficiency == Factor XIII deficiency, while generally rare, does occur, with Iran having the highest global incidence of the disorder with 473 cases. The city of Khash, located in Sistan and Balochistan provinces, has the highest incidence in Iran, with a high rate of consanguineous marriage.

Sources: en.wikipedia.org

Further detail

== Membrane exchange chromatography == A type of ion exchange chromatography, membrane exchange is a relatively new method of purification designed to overcome limitations of using columns packed with beads. Membrane Chromatographic devices are cheap to mass-produce and disposable unlike other chromatography devices that require maintenance and time to revalidate. There are three types of membrane absorbers that are typically used when separating substances. The three types are flat sheet, hollow fibre, and radial flow. The most common absorber and best suited for membrane chromatography is multiple flat sheets because it has more absorbent volume. It can be used to overcome mass transfer limitations and pressure drop, making it especially useful for isolating and purifying viruses, plasmid DNA, and other large macromolecules. The column is packed with microporous membranes with internal pores which contain adsorptive moieties that can bind the target protein. Adsorptive membranes are available in a variety of geometries and chemistry which allows them to be used for purification and also fractionation, concentration, and clarification in an efficiency that is 10 fold that of using beads. Membranes can be prepared through isolation of the membrane itself, where membranes are cut into squares and immobilized. A more recent method involved the use of live cells that are attached to a support membrane and are used for identification and clarification of signaling molecules.

The Kew Fungarium accessions thousands of fungal specimens each year and operates specimen loans and visitor access comparable to a research library for fungal material. Fungaria more generally may provide on-site access and specimen loans for researchers, and their holdings are sometimes used for teaching and exhibitions. Destructive sampling is permitted within limits at Kew to support molecular work, including projects aimed at extracting genomic data from preserved fungi. Even relatively small fungaria may contain substantial undocumented diversity; in a study of the roughly 14,000-specimen Larry F. Grand Mycological Herbarium, molecular re-examination of powdery mildew specimens led to widespread redeterminations and the recognition of four previously undescribed species.

=== Commercial === Commercial availability varies by country. Approved systems in various countries, described further below, include MiniMed 670G or 780G, Tandem's Control-IQ, Omnipod 5, CamAPS FX, and Diabeloop DBLG1.

=== Pituitary === Pituitary prolactin is controlled by the Pit-1 transcription factor, which binds to the gene at several sites including a proximal promoter. This promoter is inhibited by dopamine and stimulated by estrogens, neuropeptides, and growth factors. Estrogens can also suppress dopamine. Interaction with neuropeptides is still a matter of active research: no specific prolactin-releasing hormone has been identified. It is known that mice react to both VIP and TRH, but humans seem to only react to TRH. There are prolactin-releasing peptides that work in vitro, but whether they deserve their name has been questioned. Oxytocin does not play a large role. Mice without a posterior pituitary do not raise their prolactin levels even with suckling and oxytocin injection, but scientists have yet to identify which specific hormone produced by this region is responsible. In birds (turkeys), VIP is a powerful prolactin-releasing factor, while peptide histidine isoleucine has almost no effect.

Sources: en.wikipedia.org

Background from the literature

=== Immune compromise === The immune response is impaired in individuals with diabetes mellitus. Cellular studies have shown that hyperglycemia both reduces the function of immune cells and increases inflammation.

=== DVD documentary === A DVD documentary is a documentary film of indeterminate length that has been produced with the sole intent of releasing it for direct sale to the public on DVD, which is different from a documentary being made and released first on television or on a cinema screen (a.k.a. theatrical release) and subsequently on DVD for public consumption. This form of documentary release is becoming more popular and accepted as costs and difficulty with finding TV or theatrical release slots increases. It is also commonly used for more "specialist" documentaries, which might not interest a wider TV audience. Examples are military, cultural arts, transport, sports, animals, etc.

== Environmental effects == Considering the volume of polyacrylamide produced, these materials have been heavily scrutinized with regards to environmental and health impacts. Polyacrylamide is of low toxicity but its precursor acrylamide is a neurotoxin and carcinogen. Thus, concerns naturally center on the possibility that polyacrylamide is contaminated with acrylamide. Considerable effort is made to scavenge traces of acrylamide from the polymer intended for use near food. Additionally, there are concerns that polyacrylamide may de-polymerise to form acrylamide. Under conditions typical for cooking, polyacrylamide does not de-polymerise significantly. The single claim that polyacrylamide reverts to acrylamide has been widely challenged. Polyacrylamide is most commonly partially biodegraded by the action of amidases, producing ammonia and polyacrylates. Polyacrylates are hard to biodegrade, but some soil microbe cultures have been shown to do so in aerobic conditions.

Sources: en.wikipedia.org

Frequently asked questions

胸腺素α1是激素吗?

它不是经典的内分泌激素,而是一种免疫调节肽。其作用主要通过局部免疫细胞间的信号传递实现,而非经血液循环作用于远隔器官。

天然来源是什么?

天然胸腺素α1主要从胸腺组织提取,也可在脾脏和淋巴结中检出。目前研究和临床使用的多为化学合成版本,不再依赖动物组织。

它和胸腺素组分5有什么关系?

胸腺素组分5是牛胸腺提取物的粗组分,包含多种肽。胸腺素α1是其中一种被纯化和表征的单一肽,具有明确的28个氨基酸序列。

Is thymosin alpha-1 a naturally occurring hormone?

It corresponds to a fragment of the larger protein prothymosin alpha, which is present in many tissues. The isolated 28-amino-acid peptide was originally obtained from thymus preparations, and the pharmaceutical product is synthesized rather than extracted. The term therefore describes both a natural fragment and a manufactured drug substance.

Network